Search results for "Angina"

showing 10 items of 211 documents

Thrombolysis with saruplase versus streptokinase in acute myocardial infarction: five-year results of the PRIMI trial.

1999

Abstract Background Short-term safety and efficacy of thrombolysis with saruplase in acute myocardial infarction have been shown in several trials. To assess long-term outcome of patients treated with saruplase or streptokinase for myocardial infarction, a 5-year follow-up of patients included in the Pro-Urokinase in Myocardial Infarction Trial was performed. Methods and Results Follow-up data are available from 8 centers on 255 (92.4%) of 276 included patients. The 5-year mortality rate was comparable with 20.8% of patients in the saruplase group and 16.9% in the streptokinase group (odds ratio 1.29, 95% confidence interval 0.69 to 2.42). In both groups, a considerable number of fatal card…

Malemedicine.medical_specialtyStreptokinasemedicine.medical_treatmentMyocardial InfarctionAnginaCohort StudiesFibrinolytic AgentsRecurrenceAngioplastyInternal medicineMedicineHumansStreptokinaseThrombolytic TherapyMyocardial infarctionAngioplasty Balloon CoronaryCoronary Artery BypassAgedbusiness.industryOdds ratioThrombolysisMiddle Agedmedicine.diseaseSurvival AnalysisUrokinase-Type Plasminogen ActivatorConfidence intervalRecombinant ProteinsCerebrovascular DisordersCardiologySaruplaseFemaleCardiology and Cardiovascular Medicinebusinessmedicine.drugFollow-Up StudiesAmerican heart journal
researchProduct

Subclavian Stenosis/Occlusion in Patients with Subclavian Steal and Previous Bypass of Internal Mammary Interventricular Anterior Artery: Medical or …

2004

There are only a few published studies on the association between subclavian steal syndrome and ischemic heart disease. The objective of this report is to evaluate the efficacy of subclavian stenoocclusion treatment in patients with subclavian steal syndrome (SSS) and previous cor- onary bypass. Over the last 8 years we observed 207 patients who underwent left internal mammary artery–intraventricular artery (LIMA–IVA) bypass graft. Of these, 31 patients were affected by steno-occlusion of the homolateral subclavian artery. Ten patients (group 1) showed latent vertebral-SSS and were pharmacologically treated. Seven patients (group 2) had an intermittent vertebral-SSS; four patients were trea…

Malemedicine.medical_specialtyTiclopidinemedicine.medical_treatmentConstriction PathologicSubclavean stenosis/occlusionAnginaSubclavian Steal SyndromeRestenosisRisk FactorsInternal medicinemedicine.arteryAngioplastymedicineHumanscardiovascular diseasesInternal Mammary-Coronary Artery AnastomosisSubclavian arteryAgedAspirinmedicine.diagnostic_testbusiness.industryAngioplastyStentGeneral MedicineMiddle Agedmedicine.diseaseSurgerybody regionssurgical procedures operativeAngiographycardiovascular systemCardiologyPlatelet aggregation inhibitorFemaleStentsSurgeryCardiology and Cardiovascular MedicinebusinessSubclavian steal syndromePlatelet Aggregation InhibitorsAnnals of Vascular Surgery
researchProduct

Prognosis in patients with microvascular angina: A clinical follow-up

2019

Malemedicine.medical_specialtyTime Factorschest painMEDLINEmicrocirculationChest painMicrocirculationText miningRecurrenceRisk FactorsCause of DeathInternal medicineHumansMedicineIn patientAgedCause of deathbusiness.industryDisease progressionMicrovascular anginaCardiovascular AgentsRecovery of FunctionGeneral MedicineMiddle AgedTreatment Outcomemicrovascular anginaDisease ProgressionoutcomeFemalemedicine.symptomCardiology and Cardiovascular Medicinebusiness
researchProduct

Safety and tolerability of abciximab in patients with acute myocardial infarction and failed thrombolysis.

2003

Abstract Aim: The aim of this study was to evaluate glycoprotein IIb/IIIa receptor inhibitor effectiveness in AMI patients with unsuccessful thrombolysis. Methods: Eighty-four patients hospitalised within 4 h of symptom onset were randomised (single blind) into two groups. Regardless of the group, placebo or GP IIb/IIIa inhibitors were administered to patients who did not present with reperfusion signs 30 min after starting thrombolysis and 30–60 min after the end of full thrombolysis in patients with pain recurrence and ST-segment elevation. Reperfusion was assessed by the creatine kinase peak occurring within 12 h, by the observation of rapid ST-segment reduction (50–70% within 1 h) in 12…

Malemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentAbciximabMyocardial InfarctionMyocardial ReperfusionPlatelet Glycoprotein GPIIb-IIIa ComplexPlaceboCoronary AngiographyAnginaElectrocardiographyImmunoglobulin Fab FragmentsInternal medicineFibrinolysisAbciximabmedicineHumansSingle-Blind MethodThrombolytic TherapyMyocardial infarctionTreatment FailureAngioplasty Balloon CoronaryAspirinbusiness.industryAntibodies MonoclonalThrombolysisMiddle Agedmedicine.diseaseTolerabilityResearch DesignAnesthesiaTissue Plasminogen ActivatorCardiologyFemaleSafetyCardiology and Cardiovascular MedicinebusinessPlatelet Aggregation Inhibitorsmedicine.drugInternational journal of cardiology
researchProduct

Recanalization of occluded left main coronary artery in unstable angina pectoris

1984

Malemedicine.medical_specialtybusiness.industryUnstable anginaMiddle AgedCoronary Angiographymedicine.diseaseCoronary VesselsAngina Pectorismedicine.anatomical_structureInternal medicineCardiologyHumansMedicineAngina UnstableCardiology and Cardiovascular MedicinebusinessAngioplasty BalloonArteryThe American Journal of Cardiology
researchProduct

Quality-of-Life and Economic Outcomes of Assessing Fractional Flow Reserve With Computed Tomography Angiography: PLATFORM.

2015

International audience; BACKGROUND: Fractional flow reserve estimated using computed tomography (FFRCT) might improve evaluation of patients with chest pain. OBJECTIVES: The authors sought to determine the effect on cost and quality of life (QOL) of using FFRCT instead of usual care to evaluate stable patients with symptoms suspicious for coronary disease. METHODS: Symptomatic patients without known coronary disease were enrolled into 2 strata based on whether invasive or noninvasive diagnostic testing was planned. In each stratum, consecutive observational cohorts were evaluated with either usual care or FFRCT. The number of diagnostic tests, invasive procedures, hospitalizations, and medi…

Malemedicine.medical_specialtycost comparisonVisual analogue scale*Fractional Flow Reserve[SDV]Life Sciences [q-bio]Fractional flow reserveCoronary Artery Disease030204 cardiovascular system & hematologyChest painCoronary Angiography030218 nuclear medicine & medical imagingCoronary artery diseaseAnginaCohort Studiesquality of life03 medical and health sciencesCoronary Artery Disease/*economics/*radiography/therapy0302 clinical medicineQuality of lifeEQ-5DmedicineHumansLongitudinal StudiesProspective StudiesMyocardial/physiologyTomographyComputed tomography angiography*Quality of Lifemedicine.diagnostic_testbusiness.industryX-Ray Computed/*economicsMiddle Agedmedicine.diseaseCoronary Angiography/*economics3. Good healthFractional Flow Reserve MyocardialTreatment OutcomePhysical therapyQuality of Lifestress testFemalemedicine.symptombusinessCardiology and Cardiovascular MedicineTomography X-Ray Computedmyocardial fractional flow reserveJournal of the American College of Cardiology
researchProduct

Risk Factors of Coronary Artery Disease in Secondary Prevention—Results from the AtheroGene—Study

2015

Background Risk factors are important in cardiovascular (CV) medicine for risk stratification of patients. We aimed to compare the traditional risk factors to clinical variables for the prediction of secondary cardiovascular events. Methods and Results For this study, 3229 patients with known coronary artery disease (CAD) were included. We calculated whether the traditional risk factors, diabetes mellitus, increased LDL/HDL ratio, arterial hypertension and smoking alone and in combination with the clinical variables, ejection fraction, creatinine clearance, multi-vessel disease and CRP concentration predict the outcome cardiovascular death or non-fatal myocardial infarction (N = 432) during…

Malemedicine.medical_specialtylcsh:MedicineRenal functionCoronary Artery DiseaseCoronary artery diseaseAnginaCohort StudiesRisk FactorsInternal medicineDiabetes mellitusmedicineSecondary PreventionHumansMyocardial infarctionRisk factorlcsh:ScienceProportional Hazards ModelsMultidisciplinarybusiness.industrylcsh:RHazard ratioMiddle Agedmedicine.diseaseCardiologyRegression Analysislcsh:QFemalebusinessCohort studyResearch ArticleFollow-Up StudiesPLoS ONE
researchProduct

Circulating adhesion molecules, matrix metalloproteinase-9, plasminogen activator inhibitor-1, and myeloperoxidase in coronary artery disease patient…

2010

There are many pathophysiological mechanisms underlying reciprocal relationships between changes in cytokines and insulin resistance in metabolic and cardiovascular disorders. The aim of this study was to evaluate alterations in soluble intercellular adhesion molecule-1 (sICAM-1), soluble vascular cell adhesion molecule-1 (sVCAM-1), soluble E-selectin (sE-selectin), matrix metalloproteinase-9 (MMP-9), plasminogen activator inhibitor-1 (PAI-1), and myeloperoxidase (MPO) levels, and their relation to insulin resistance in coronary artery disease (CAD) patients with stable and unstable angina (SAP, UAP).Non-diabetic CAD patients were classified into two groups: 22 patients with SAP and 22 pati…

Malemedicine.medical_specialtymedicine.medical_treatmentClinical BiochemistryCoronary Artery DiseaseBiochemistryAngina PectorisCoronary artery diseasechemistry.chemical_compoundInsulin resistanceInternal medicinePlasminogen Activator Inhibitor 1medicineHumansAgedPeroxidasebiologyCell adhesion moleculeUnstable anginabusiness.industryBiochemistry (medical)General MedicineMiddle Agedmedicine.diseaseEndocrinologyCytokineMatrix Metalloproteinase 9chemistryCase-Control StudiesMyeloperoxidasePlasminogen activator inhibitor-1biology.proteinFemaleInsulin ResistancebusinessCell Adhesion MoleculesPlasminogen activatorClinica Chimica Acta
researchProduct

Results of intracoronary stents for management of coronary dissection after balloon angioplasty.

1991

Dissections after coronary balloon angioplasty are risk factors for acute or subacute vessel closures. Intracoronary stenting was developed to avoid these complications by pressing the intimal and medial flaps against the vessel wall, thus reducing the risk of acute thrombosis. A total of 22 stents were implanted into the coronary arteries of 15 patients with dissections after balloon angioplasty causing angina pectoris or ischemic electrocardiographic changes. Stent delivery was successful in all cases. In 1 patient acute stent thrombosis was documented and treated successfully by thrombolytic therapy. Another patient underwent coronary artery bypass surgery 24 hours later because of persi…

Malemedicine.medical_specialtymedicine.medical_treatmentCoronary DiseaseBalloonAngina PectorisAnginaCoronary artery bypass surgeryRestenosisInternal medicineAngioplastyMedicineHumanscardiovascular diseasesAngioplasty Balloon CoronaryAgedRupturebusiness.industryStentMiddle Agedequipment and suppliesmedicine.diseaseCoronary VesselsSurgeryCoronary arteriesRadiographyDissectionmedicine.anatomical_structureCardiologyFemaleStentsCardiology and Cardiovascular MedicinebusinessThe American journal of cardiology
researchProduct

Emergency angioplasty of totally occluded left main coronary artery in acute myocardial infarction and unstable angina pectoris--institutional experi…

1994

Acute occlusion of the left main coronary artery (LMCA) is a rare angiographic finding. We report five patients with acute myocardial infarction (AMI) and one patient with unstable angina, in whom reperfusion was achieved or attempted with percutaneous transluminal coronary angioplasty (PTCA). All patients had a long history of stable angina pectoris. The indication for emergency PTCA was cardiogenic shock in the five patients with MI. PTCA was successful in five of six patients. Three patients with reperfusion survived, three died. All survivors underwent coronary artery bypass grafting (CABG) and were still alive at 23 months, 3 and 8 years respectively in NYHA functional class II or III.…

Malemedicine.medical_specialtymedicine.medical_treatmentMyocardial InfarctionShock CardiogenicCollateral CirculationAnginaCoronary artery bypass surgeryReperfusion therapyLeft coronary arterymedicine.arteryInternal medicineAngioplastyCoronary CirculationmedicineHumanscardiovascular diseasesMyocardial infarctionAngina UnstableAngioplasty Balloon CoronaryCoronary Artery BypassAgedUnstable anginabusiness.industryMiddle Agedmedicine.diseaseSurgerysurgical procedures operativeTreatment OutcomeRight coronary arteryCardiologyFemaleEmergenciesCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesEuropean heart journal
researchProduct